Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H29F3N2O2 |
Molecular Weight | 494.548 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CCC3=CC(=CC=C3[C@]1(CC4=CC=CC=C4)CC[C@@](O)(C2)C(F)(F)F)C(=O)NC5=CC=CN=C5C
InChI
InChIKey=QJJBNCHSWFGXML-KEKPKEOLSA-N
InChI=1S/C29H29F3N2O2/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(36,29(30,31)32)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23,36H,9,11,13-14,17-18H2,1H3,(H,34,35)/t23-,27+,28-/m1/s1
Molecular Formula | C29H29F3N2O2 |
Molecular Weight | 494.548 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacokinetics and food-effect of fosdagrocorat (PF-04171327), a dissociated agonist of the glucocorticoid receptor, in healthy adult Caucasian and Japanese subjects . | 2016 Dec |
|
Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study. | 2017 Aug |
|
Population Pharmacokinetics of Fosdagrocorat (PF-04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis. | 2018 Jan |
|
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study. | 2019 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:42:55 GMT 2023
by
admin
on
Sat Dec 16 01:42:55 GMT 2023
|
Record UNII |
OPM23UN90U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1044535-52-5
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
C174807
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
9842
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
OPM23UN90U
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
CHEMBL3137304
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
24873449
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
DB14676
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
300000034052
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
AB-23
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
DTXSID60146493
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY | |||
|
Dagrocorat
Created by
admin on Sat Dec 16 01:42:55 GMT 2023 , Edited by admin on Sat Dec 16 01:42:55 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET->PARTIAL AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|